Stem Cells 4 U?

Stem cell medicines will revolutionize medical therapies and there is a lot of enthusiasm about their potential at all levels of our society especially in the news media, blogs, social sites, and in advertisements. Some truly remarkable advances in stem cell medicine may however go unnoticed because they are not deemed as newsworthy, are not as attractive to investors, or are not relevant to political advances. This book is not meant to teach the reader about stem cells in a scholarly way. Rather, it will explain the relevance of the different stem cells in the context of potential medical applications. Its ultimate goal is provide unbiased and easy to follow information to you, the interested reader, the patient, the concerned parent, or even the curious investor to be better positioned to identify credible medical progress and what it holds for the future. Although the potential of stem cells for tissue engineering and regenerative medicine is very real and promising, it is often ignored that for decades, cancer specialists have been performing adult stem cell transplants using bone marrow stem cells, initially from siblings and later also from unrelated volunteer donors or umbilical cord blood. Among the many diseases that can now be treated with a bone marrow stem cell transplant, leukemia, lymphoma, and myeloma are the most common. This book tells the stories of patients whose lives have been transformed by this remarkable procedure. The author's career as a stem cell transplant physician and scientist on the forefront of this medical revolution has afforded him the opportunity to talk to numerous patients and laymen about this topic and learn the importance of presenting this complex field balanced and easy to comprehend.
About the Author: About the Author Dr. Hans Klingemann is the Director of the Bone Marrow and Stem Cell Transplant Program at Tufts Medical Center in Boston and Professor of Medicine at Tufts University Medical School. He also directs the Hematological Malignancies Program at the Tufts Medical Center Cancer Center and runs a stem cell transplant research laboratory. Dr. Klingemann has worked as a physician, scientist, educator, and administrator in leadership positions for over twenty years at various academic medical centers, has written over 150 scientific and medical papers and edited four books. He serves as editor and reviewer of several stem cell transplant journals and is a reviewer for the National Institutes of Health. He holds numerous patents and was one of the first researchers to describe the role of cord mesenchymal stem cells in transplant.